Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
EARLY_PHASE1
35 participants
INTERVENTIONAL
2017-07-11
2017-11-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Safety Study of Methylphenidate Hydrochloride Extended Release in Adults With Childhood-onset Attention Deficit/Hyperactivity Disorder (ADHD)
NCT01259492
Impact of Attention Deficit/Hyperactivity Disorder and Substance Use Disorder on Motorcycle Traffic Accidents
NCT00536419
Motivated Behavior in Adults With and Without ADHD
NCT02630017
The Effect of Methylphenidate Treatment in Familial Attention Deficit/Hyperactivity Disorder (ADHD)
NCT01554046
A Study of the Effectiveness and Safety of Prolonged-release Methylphenidate Hydrochloride in Adult Patients With Attention Deficit/Hyperactivity Disorder.
NCT00246220
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
methylphenidate then placebo
Ritalin 10Mg Tablet
oral ingestion of 3 tablets in a single-dose
Placebo Oral Tablet
oral ingestion of 3 tablets in a single-dose
placebo then methylphenidate
Ritalin 10Mg Tablet
oral ingestion of 3 tablets in a single-dose
Placebo Oral Tablet
oral ingestion of 3 tablets in a single-dose
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ritalin 10Mg Tablet
oral ingestion of 3 tablets in a single-dose
Placebo Oral Tablet
oral ingestion of 3 tablets in a single-dose
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* free and informed consent
* social security affiliation
* no chronic illness
* no previous participation to a protocol wth similar tasks
* no special legal status (guardianship,trusteeship)
* no personnal or familial neurologic or psychiatric background
* no contraceptive device for a reproductive woman
Exclusion Criteria
* smoking
* psychoactive substance consumption less than 3 weeks ago
* pregnant or breastfeeding woman
* hypersensitivity to methylphenidate
* hyperthyroidism
* cardiovascular or cerebrovascular disease
* respiratory, hepatic or renal failure
* glaucoma
* pheochromocytoma
* gluten intolerance or hypersensitivity
* galactosemia, glucose malabsorption syndrome, lactase deficit
* countraindicated meds (IMAO, IMAO-A, orhtosympathomimetics, alcaloids, linezolin, enzymatic inducers, psycho-active drugs)
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre d'investigation clinique, Institut du Cerveau et de la Moelle
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C13-08
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.